Dr. Jacob Dubroff, MD, PhD
Claim this profileUniversity of Pennsylvania, Perelman School of Medicine
Studies Healthy Subjects
Studies Neuroinflammatory Disease
6 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Jacob Dubroff, MD, PhD is currently running
[18F]NOS Imaging
for Lung Inflammation
The purpose of this research is to measure the extent of lung inflammation between different groups of participants using a radioactive tracer called \[18F\]NOS. A radioactive tracer is a type of imaging drug that is labeled with a radioactive tag and injected into the body.
Recruiting1 award Phase 13 criteria
Opioid Receptor Binding Analysis
for Healthy Subjects
This study will enroll up to 60 adults (including 30 females and 30 males) in three cohorts of up to 20 subjects each. In all three groups, \[11C\]carfentanil whole-body PET imaging will be used to examine the central nervous system (CNS) and broader systemic opioid binding in an initial scan session. In the two groups not receiving standard of care medication assisted treatment (MAT) for opioid use disorder (OUD) the effects on \[11C\]carfentanil binding potential of the blockade of opioid binding by the non-selective opioid antagonist naloxone administered parenterally in a second scan session will also be examined. If two scans are completed they can be done on the same day or on different days.
Recruiting1 award Phase 17 criteria
More about Jacob Dubroff, MD, PhD
Clinical Trial Related6 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jacob Dubroff, MD, PhD has experience with
- [18F]NOS
- Carfentanil
- [18F]FTP PET/CT
- FNOS
- FDG
- Ketone Ester (R)-3-hydroxybutyl (R)-3-hydroxybutyrate)
Breakdown of trials Jacob Dubroff, MD, PhD has run
Healthy Subjects
Neuroinflammatory Disease
Opioid Use Disorder
Parkinson's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jacob Dubroff, MD, PhD specialize in?
Jacob Dubroff, MD, PhD focuses on Healthy Subjects and Neuroinflammatory Disease. In particular, much of their work with Healthy Subjects has involved treating patients, or patients who are undergoing treatment.
Is Jacob Dubroff, MD, PhD currently recruiting for clinical trials?
Yes, Jacob Dubroff, MD, PhD is currently recruiting for 3 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Jacob Dubroff, MD, PhD has studied deeply?
Yes, Jacob Dubroff, MD, PhD has studied treatments such as [18F]NOS, Carfentanil, [18F]FTP PET/CT.
What is the best way to schedule an appointment with Jacob Dubroff, MD, PhD?
Apply for one of the trials that Jacob Dubroff, MD, PhD is conducting.
What is the office address of Jacob Dubroff, MD, PhD?
The office of Jacob Dubroff, MD, PhD is located at: University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the University of Pennsylvania, Perelman School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.